The relatively mild cognitive and memory brain phenotypes observed in a C57BL/6 TRIB3-deficient mouse model [31] support the notion that normalizing pathological increases in TRIB3 levels in neurodegenerative disease might be an interesting new medical strategy. This evidence concerns the gene TRIB3 and neurodegenerative disease.